No Absolute Contraindication to Nexplanon in Paroxysmal Atrial Fibrillation
There is no contraindication to placing a Nexplanon implant in a woman with paroxysmal atrial fibrillation. The FDA-approved prescribing information for Nexplanon lists specific contraindications—including known or suspected pregnancy, current or past thrombosis/thromboembolic disorders, liver tumors or active liver disease, undiagnosed abnormal uterine bleeding, breast cancer or other progestin-sensitive cancers, and allergic reactions to components—but paroxysmal atrial fibrillation is not among them 1.
Key Clinical Considerations
Thrombotic Risk Assessment
The critical distinction here is between atrial fibrillation itself and thromboembolic disease:
- Atrial fibrillation alone is NOT a contraindication to progestin-only contraceptives like Nexplanon
- Active thrombosis or history of thromboembolic disorders IS a contraindication 1
You must determine whether this patient has:
- A history of stroke or systemic embolism
- Current or past venous thromboembolism (DVT/PE)
- Active thrombotic disease
If she has any of these conditions, Nexplanon is contraindicated due to the thrombotic history, not the atrial fibrillation itself.
Anticoagulation Management
Women with paroxysmal atrial fibrillation often require anticoagulation based on their CHA₂DS₂-VASc score 2. The cardiovascular disease prevention guidelines specifically state that warfarin should be used in women with chronic or paroxysmal atrial fibrillation to maintain INR 2.0-3.0 unless they are at low risk for stroke or high risk of bleeding 2.
The presence of anticoagulation therapy does not contraindicate Nexplanon placement, though it may increase bleeding risk during the insertion procedure. This is a procedural consideration, not an absolute contraindication.
Progestin-Only Methods Are Preferred in Cardiovascular Disease
Importantly, progestin-only contraceptives like Nexplanon are generally safer than combined hormonal contraceptives in women with cardiovascular conditions. The guidelines on cardiovascular disease prevention in women do not list progestin-only methods as contraindicated in women with atrial fibrillation 2.
Common Pitfalls to Avoid
Do not confuse atrial fibrillation with thromboembolic disease: The arrhythmia itself is not a contraindication; only actual thrombotic events are contraindicated 1
Do not assume all cardiovascular conditions contraindicate hormonal contraception: Progestin-only methods have a different risk profile than combined estrogen-progestin contraceptives
Do not withhold highly effective contraception unnecessarily: Nexplanon is one of the most effective reversible contraceptive methods available, and unintended pregnancy carries its own cardiovascular risks 3
Practical Approach
Before insertion:
- Verify no history of thrombosis or thromboembolic events
- Check that she meets none of the FDA-listed contraindications 1
- If on anticoagulation, ensure INR is therapeutic but consider local hemostasis measures during insertion
- Counsel about expected bleeding pattern changes (the most common adverse effect) 3
Proceed with Nexplanon insertion if no actual contraindications exist. The presence of paroxysmal atrial fibrillation alone should not prevent access to this highly effective contraceptive method.